Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $2.30M in the quarter ending March 31, 2025, a decrease of -32.51%. This brings the company's revenue in the last twelve months to $7.22M, down -48.97% year-over-year. In the year 2024, Taysha Gene Therapies had annual revenue of $8.33M, down -46.07%.

• Revenue (ttm): $7.22M
• Revenue Growth: -48.97%
• P/S Ratio: 91.29
• Revenue / Employee: $98,959
• Employees: 73
• Market Cap: 545.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.33M	-7.12M	-46.07%
Dec 31, 2023	15.45M	12.95M	517.55%
Dec 31, 2022	2.50M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.